C

    China Pharma Holdings Inc (CPHI)

    Official site

    HEALTHCARE • DRUG MANUFACTURERS - SPECIALTY & GENERIC • AMEX

    $0.89
    -0.01 (-1.34%)

    Market Cap: $38.90M

    Last updated: Sep 01, 2026 at 10:00 AM ET

    Earnings

    PeriodReportedEst.SurpriseB/MYoY
    Jun 26
    		$-0.04N/AN/ABeat+92.5%
    Sep 25
    		$-0.17$0.00N/AMiss+73.7%
    Jun 25
    		$-0.16$0.00N/AMiss+82.1%
    Mar 25
    		$-0.24N/AN/ABeat+67.0%
    Dec 24
    		$-0.53N/AN/ABeat+54.3%
    Sep 24
    		$-0.65N/AN/ABeat+78.0%
    Jun 24
    		$-0.89N/AN/ABeat+70.2%
    Mar 24
    		$-0.73N/AN/ABeat-1113.0%
    Dec 23
    		$-1.16N/AN/ABeat-479.8%
    Sep 23
    		$-2.94N/AN/ABeat-14609.0%
    Jun 23
    		$-2.99N/AN/ABeat-14851.0%
    Mar 23
    		$-0.06$0.00N/AMiss-200.0%
    Dec 22
    		$-0.20$0.00N/AMiss-900.0%
    Sep 22
    		$-0.02$0.00N/AMiss+0.0%
    Jun 22
    		$-0.02N/AN/ABeat+0.0%
    Mar 22
    		$-0.02N/AN/ABeat+0.0%
    Dec 21
    		$-0.02$0.00N/AMiss+33.3%
    Sep 21
    		$-0.02N/AN/ABeat+0.0%
    Jun 21
    		$-0.02N/AN/ABeat+13.8%
    Mar 21
    		$-0.02N/AN/ABeat+0.0%
    Dec 20
    		$-0.03N/AN/ABeat+93.0%
    Sep 20
    		$-0.02N/AN/ABeat+0.0%
    Jun 20
    		$-0.02N/AN/ABeat-16.0%
    Mar 20
    		$-0.02N/AN/ABeat+88.2%
    Dec 19
    		$-0.43N/AN/ABeat-4379.2%
    Sep 19
    		$-0.02N/AN/ABeat+50.0%
    Jun 19
    		$-0.02N/AN/ABeat+0.0%
    Mar 19
    		$-0.17N/AN/ABeat+46.9%
    Dec 18
    		$-0.01$0.00N/AMiss-43.3%
    Sep 18
    		$-0.04N/AN/ABeat+20.0%
    Jun 18
    		$-0.02N/AN/ABeat+60.0%
    Mar 18
    		$-0.32N/AN/ABeat-1500.0%
    Dec 17
    		$-0.01$0.00N/AMiss+69.8%
    Sep 17
    		$-0.05N/AN/ABeat-162.5%
    Jun 17
    		$-0.05N/AN/ABeat-
    Mar 17
    		$-0.02N/AN/ABeat-
    Dec 16
    		$-0.02$0.00N/AMiss-
    Sep 16
    		$0.08N/AN/ABeat-

    Key Metrics

    Valuation
    P/E Ratio-1.46EV/EBITDA-225.89x
    Price/FCFN/AFCF YieldN/A
    Profitability
    Profit Margin-114.30%Operating Margin-151.00%
    ROE-21.00%ROIC-8.69%
    Financial Health
    Debt/Equity0.10xInterest Coverage-44.20x
    Current Ratio0.26xQuick Ratio0.08x
    Trading Statistics
    Beta1.07Avg Volume1.03M
    52-Week High$8.1052-Week Low$0.50

    Technical Indicators Dashboard

    Moving Averages

    SMA 10$0.96
    SMA 20$1.05
    SMA 50$1.13
    SMA 200$0.99
    EMA 10$0.96
    EMA 20$1.05
    EMA 50$1.08
    EMA 200$1.10

    MACD

    Line: -0.10Signal: -0.07Hist: -0.02

    ADX

    ADX: 79.7+DI: 52.0-DI: 6.4

    Aroon & PSAR

    Aroon UpN/A
    Aroon Down84.0
    PSAR$1.68

    Bollinger Bands

    Upper Band$1.29
    Lower Band$0.82
    %B Position4493%(Upper)
    Band Width0.16

    RSI (14-Day)

    Neutral
    45.7

    Momentum Oscillators

    Stoch %K9.0
    Stoch %D8.5
    Williams %R-91.6
    ROC (10d)-17.4%
    Momentum-0.19
    CCI (20d)-110.1
    MFI (14d)6.4

    Volatility Measures

    ATR (14d)$0.33(36.9%)
    StdDev (20d)0.12
    Hist Vol63.8%(High)

    Volume Flow

    VWAP$0.91
    OBV145.7M
    AD Line2.6B
    CMF (20d)-0.425

    Volume Metrics

    Avg Vol (20d)1.1M
    Vol Ratio0.4x(Low)
    VWMA (20d)$1.10

    Pivot Points

    R3$0.95
    R2$0.94
    R1$0.92
    Pivot Point$0.90
    S1$0.89
    S2$0.87
    S3$0.85

    Advanced Oscillators

    TSI-5.56
    Ultimate Osc28.1
    KST3.01

    Financial Data

    QuarterJun 2026Mar 2026Dec 2025Sep 2025Jun 2025Mar 2025Dec 2024Sep 2024Jun 2024Mar 2024Dec 2023Sep 2023
    Total Revenue$948,340$983,536$1.23M$756,217$1.03M$1.14M$1.13M$1.10M$924,943$1.37M$2.15M$1.80M
    Cost of Revenue$864,774$698,049$1.07M$815,871$1.11M$1.27M$1.30M$1.62M$1.94M$1.66M$2.22M$2.04M
    Gross Profit$83,566$285,487$152,807$-59,654$-89,042$-136,061$-160,589$-519,649$-1,015,386$-290,024$-75,111$-233,190
    Operating Expenses$1.52M$1.40M$1.35M$568,491$412,388$622,557$1.03M$567,264$376,135$626,028$1.11M$480,352
    R&D$19,135$83,762$189,175$40,321$-129,738$29,587$547$87,610$164,334$31,451$147,552$45,773
    SG&A$1.49M$1.32M$1.19M$502,868$542,126$594,293$1.03M$479,654$203,325$596,643$949,337$452,791
    Operating Income$-1,431,845$-1,117,264$-1,200,195$-628,145$-652,120$-758,618$-1,196,036$-1,085,257$-1,391,521$-916,052$-1,184,491$-713,542
    Interest Income$81$147$213$294$422$1,074$1,335$1,460$1,531$2,315$2,530$2,182
    Interest Expense$26,359$26,031$22,604$24,046$27,359$28,028$29,731$34,114$48,140$42,155$50,252$66,240
    Income Before Tax$-1,458,123$-1,143,148$-1,222,135$-651,482$-528,367$-785,572$-1,224,432$-1,117,911$-1,438,130$-955,892$-1,232,213$-777,600
    Income Tax Expense$0$0$0$0$0$0$0$0$0$0$0$0
    Net Income$-1,458,123$-1,143,148$-1,222,135$-651,482$-528,367$-785,572$-1,224,432$-1,117,911$-1,438,130$-955,892$-1,232,213$-777,600
    EBITDA$-329,990$-136,694$-627,236$-272,111$-331,257$-429,305$-689,032$-388,314$-652,269$-182,254$-488,656$-30,448
    EBIT$-1,431,845$-1,117,264$-1,200,195$-628,145$-652,120$-758,618$-1,196,036$-1,085,257$-1,391,521$-916,052$-1,184,491$-713,542
    * Some calculated fields are derived from available data when not provided by source

    Related GNG Research

    No research available

    Be the first to write about CPHI

    News

    CPHI Stock Craters As $5M Offering Fuels Extreme Volatility

    China Pharma Holdings Inc. (CPHI) stock experienced a significant drop of over 12% following news of a $5 million registered direct offering priced at $2.00 per share. This offering, intended for working capital and general corporate needs, fueled extreme volatility and a 77% intraday collapse, resetting market expectations. The company's financials show razor-thin margins and deep unprofitability, making it highly sensitive to financing news and creating a speculative trading environment rather than a fundamentals-driven one.

    timothysykes.com•8/14/26•
    Bearish

    CPHI Stock Craters As $5M Offering Fuels Extreme Volatility

    China Pharma Holdings Inc. (CPHI) stock experienced extreme volatility and a significant drop of 77% intraday after announcing a $5 million registered direct offering at $2.00 per share. This offering, intended for working capital and general corporate needs, is perceived by traders as survival capital leading to substantial dilution. Despite inquiries from NYSE American, the company stated it is unaware of any undisclosed material events driving the wild price swings, emphasizing the speculative and liquidity-driven nature of the current market activity.

    Timothy Sykes•8/13/26•
    Bearish

    CPHI Stock Crashes As Direct Offering Fuels Volatility

    China Pharma Holdings Inc. (CPHI) stock experienced a significant drop following a $5 million registered direct offering priced at $2.00 per share, raising concerns about dilution and liquidity. The offering coincided with a 77% intraday share-price collapse, despite the company stating it was unaware of any undisclosed material information. CPHI's poor financial performance, including low revenue and negative profit margins, indicates that its stock movements are largely driven by liquidity concerns and capital raises rather than earnings growth.

    StocksToTrade•8/13/26•
    Bearish

    China Pharma Holdings Inc (CPHI) Stock News Today

    This article provides current stock news for China Pharma Holdings Inc (CPHI), including its latest stock price, market capitalization, and P/E TTM ratio. It notes that more news, earnings, analyst ratings, and key developments will be available soon. The content emphasizes that TradingKey offers general investment information and does not provide financial advice.

    TradingKey•8/8/26•
    Somewhat-Bearish

    China Pharma Holdings Inc (CPHI) Earnings Forecast: Future EPS & Revenue Growth Estimates

    This article provides an earnings forecast for China Pharma Holdings Inc (CPHI), focusing on future EPS and revenue growth estimates. It includes current stock data, market capitalization, and P/E ratio, along with a list of peer companies for comparison. The information was updated on August 7, 2026.

    TradingKey•8/6/26•
    Neutral

    Frequently Asked Questions About CPHI

    Does CPHI pay dividends?
    China Pharma Holdings Inc (CPHI) does not currently pay a regular dividend.
    What is CPHI's market cap?
    China Pharma Holdings Inc (CPHI) has a market capitalization of $38.90M with a current stock price of $0.89.

    Get full access to GNG Research

    Create a free account to access portfolio tracking, advanced tools, and more.

    Create Free AccountLog In